Immune Tolerance Network (UM1 Clinical Trial Required)

<p>The purpose of this notice of funding opportunity (NOFO) is to support&nbsp;applications to continue the Immune Tolerance Network (ITN).&nbsp;The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.</p>